{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:01:30Z","timestamp":1793746890998,"version":"4.6.1"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Microbiome"],"DOI":"10.1186\/s40168-024-01990-y","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T03:34:35Z","timestamp":1736825675000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Discovery of robust and highly specific microbiome signatures of non-alcoholic fatty liver disease"],"prefix":"10.1186","volume":"13","author":[{"given":"Emmanouil","family":"Nychas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Marfil-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuqiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Mirhakkak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huating","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik Bj\u00f8rn","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Nieuwdorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Loomba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueqiong","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianni","family":"Panagiotou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,14]]},"reference":[{"key":"1990_CR1","doi-asserted-by":"crossref","unstructured":"Loomba R, Sanyal AJ. The global NAFLD epidemic. Nat. Rev. Gastroenterol. Hepatol. 2013. p. 686\u201390.","DOI":"10.1038\/nrgastro.2013.171"},{"key":"1990_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15252\/emmm.201809302","volume":"11","author":"AA Kolodziejczyk","year":"2019","unstructured":"Kolodziejczyk AA, Zheng D, Shibolet O, Elinav E. The role of the microbiome in NAFLD and NASH. EMBO Mol Med. 2019;11:1\u201313.","journal-title":"EMBO Mol Med"},{"key":"1990_CR3","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cmet.2017.04.001","volume":"25","author":"R Loomba","year":"2017","unstructured":"Loomba R, Seguritan V, Li W, Long T, Klitgord N, Bhatt A, et al. Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease. Cell Metab. 2017;25:1054-1062.e5.","journal-title":"Cell Metab"},{"key":"1990_CR4","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.cmet.2020.06.005","volume":"32","author":"TG Oh","year":"2020","unstructured":"Oh TG, Kim SM, Caussy C, Fu T, Guo J, Bassirian S, et al. A Universal Gut-Microbiome-Derived Signature Predicts Cirrhosis. Cell Metab. 2020;32:878-888.e6.\u00a0Available from:\u00a0https:\/\/doi.org\/10.1016\/j.cmet.2020.06.005.","journal-title":"Cell Metab."},{"key":"1990_CR5","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.cmet.2022.03.002","volume":"34","author":"Y Liu","year":"2022","unstructured":"Liu Y, M\u00e9ric G, Havulinna AS, Teo SM, \u00c5berg F, Ruuskanen M, et al. Early prediction of incident liver disease using conventional risk factors and gut-microbiome-augmented gradient boosting. Cell Metab. 2022;34:719-730.e4.","journal-title":"Cell Metab"},{"issue":"648","key":"1990_CR6","doi-asserted-by":"crossref","first-page":"eabk0855","DOI":"10.1126\/scitranslmed.abk0855","volume":"14","author":"H Leung","year":"2022","unstructured":"Leung H, Long X, Ni Y, Qian L, Nychas E, Siliceo SL, et al. Risk assessment with gut microbiome and metabolite markers in NAFLD development. Sci Transl Med. 2022;14(648):eabk0855.","journal-title":"Sci Transl Med."},{"key":"1990_CR7","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.cmet.2023.08.002","volume":"35","author":"Y Ni","year":"2023","unstructured":"Ni Y, Qian L, Siliceo SL, Long X, Nychas E, Liu Y, et al. Resistant starch decreases intrahepatic triglycerides in patients with NAFLD via gut microbiome alterations. Cell Metab. 2023;35:1530-1547.e8.","journal-title":"Cell Metab"},{"key":"1990_CR8","doi-asserted-by":"publisher","unstructured":"Aron-Wisnewsky J, Vigliotti C, Witjes J, Le P, Holleboom AG, Verheij J, et al. Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders. Nat Rev Gastroenterol Hepatol. Available from: https:\/\/doi.org\/10.1038\/s41575-020-0269-9.\u00a0Cited 2022 Jan 28.","DOI":"10.1038\/s41575-020-0269-9"},{"key":"1990_CR9","doi-asserted-by":"publisher","unstructured":"Kuchay MS, Ignacio Mart\u00ednez-Montoro J, Choudhary NS, Carlos Fern\u00e1ndez-Garc\u00eda J, Ramos-Molina B, Pericas JM. Non-Alcoholic Fatty Liver Disease in Lean and Non-Obese Individuals: Current and Future Challenges. biomedicines [Internet]. 2021; Available from: https:\/\/doi.org\/10.3390\/biomedicines9101346.","DOI":"10.3390\/biomedicines9101346"},{"key":"1990_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/advs.202104373","volume":"9","author":"M Zeybel","year":"2022","unstructured":"Zeybel M, Arif M, Li X, Altay O, Yang H, Shi M, et al. Multiomics Analysis Reveals the Impact of Microbiota on Host Metabolism in Hepatic Steatosis. Adv Sci. 2022;9:1\u201320.","journal-title":"Adv Sci"},{"key":"1990_CR11","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41591-018-0308-z","volume":"25","author":"B Yilmaz","year":"2019","unstructured":"Yilmaz B, Juillerat P, \u00d8y\u00e5s O, Ramon C, Bravo FD, Franc Y, et al. Microbial network disturbances in relapsing refractory Crohn\u2019s disease. Nat Med. 2019;25:323\u201336.","journal-title":"Nat Med"},{"key":"1990_CR12","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41591-021-01289-7","volume":"27","author":"M Mac Aog\u00e1in","year":"2021","unstructured":"Mac Aog\u00e1in M, Narayana JK, Tiew PY, Ali NABM, Yong VFL, Jaggi TK, et al. Integrative microbiomics in bronchiectasis exacerbations. Nat Med. 2021;27:688\u201399.","journal-title":"Nat Med"},{"key":"1990_CR13","doi-asserted-by":"publisher","unstructured":"Yuan J, Chen C, Cui J, Lu J, Yan C, Wei X, et al. Fatty Liver Disease Caused by High-Alcohol-Producing Klebsiella pneumoniae. Cell Metab. 2019;30:675\u2013688.e7. Available from: https:\/\/doi.org\/10.1016\/j.cmet.2019.08.018.","DOI":"10.1016\/j.cmet.2019.08.018"},{"key":"1990_CR14","doi-asserted-by":"publisher","unstructured":"Seo B, Jeon K, Moon S, Lee K, Kim WK, Jeong H, et al. Roseburia spp. Abundance Associates with Alcohol Consumption in Humans and Its Administration Ameliorates Alcoholic Fatty Liver in Mice. Cell Host Microbe. 2020;27:25\u201340.e6. Available from: https:\/\/doi.org\/10.1016\/j.chom.2019.11.001.","DOI":"10.1016\/j.chom.2019.11.001"},{"key":"1990_CR15","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/s41591-019-0495-2","volume":"25","author":"C Depommier","year":"2019","unstructured":"Depommier C, Everard A, Druart C, Plovier H, Van Hul M, Vieira-Silva S, et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat Med. 2019;25:1096\u2013103.","journal-title":"Nat Med"},{"key":"1990_CR16","doi-asserted-by":"crossref","first-page":"5647","DOI":"10.1074\/jbc.M114.618249","volume":"290","author":"JC Gregory","year":"2015","unstructured":"Gregory JC, Buffa JA, Org E, Wang Z, Levison BS, Zhu W, et al. Transmission of atherosclerosis susceptibility with gut microbial transplantation. J Biol Chem. 2015;290:5647\u201360.","journal-title":"J Biol Chem"},{"key":"1990_CR17","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3389\/fcimb.2019.00455","volume":"9","author":"H Wang","year":"2020","unstructured":"Wang H, Lu Y, Yan Y, Tian S, Zheng D, Leng D, et al. Promising Treatment for Type 2 Diabetes: Fecal Microbiota Transplantation Reverses Insulin Resistance and Impaired Islets. Front Cell Infect Microbiol. 2020;9:455.","journal-title":"Front Cell Infect Microbiol."},{"key":"1990_CR18","doi-asserted-by":"publisher","unstructured":"Merrick B, Allen L, Masirah M Zain N, Forbes B, Shawcross DL, Goldenberg SD. Regulation, risk and safety of Faecal Microbiota Transplant. Infect Prev Pract. 2020;2:100069. Available from: https:\/\/doi.org\/10.1016\/j.infpip.2020.100069.","DOI":"10.1016\/j.infpip.2020.100069"},{"key":"1990_CR19","unstructured":"Safety alert regarding use of fecal microbiota for transplantation and risk of serious adverse events likely due to transmission of pathogenic organisms. Food and Drug Administration 2020. March 12,https:\/\/www.fda.gov\/safety\/medical-product-safety-informa."},{"key":"1990_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-021-23460-x","volume":"12","author":"D van der Lelie","year":"2021","unstructured":"van der Lelie D, Oka A, Taghavi S, Umeno J, Fan TJ, Merrell KE, et al. Rationally designed bacterial consortia to treat chronic immune-mediated colitis and restore intestinal homeostasis. Nat Commun. 2021;12:1\u201317.","journal-title":"Nat Commun"},{"key":"1990_CR21","doi-asserted-by":"publisher","unstructured":"Loomba R, Seguritan V, Li W, Long T, Klitgord N, Bhatt A, et al. Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease. Cell Metab. 2017;25:1054\u20131062.e5. Available from: https:\/\/doi.org\/10.1016\/j.cmet.2017.04.001.","DOI":"10.1016\/j.cmet.2017.04.001"},{"key":"1990_CR22","first-page":"918","volume":"68","author":"C Caussy","year":"2019","unstructured":"Caussy C, Hsu C, Lo M, Liu A, Bettencourt R, Veeral H, et al. Novel link between gut-microbiome derived metabolite and shared gene-effects with hepatic steatosis and fibrosis in NAFLD. 2019;68:918\u201332.","journal-title":"Novel link between gut-microbiome derived metabolite and shared gene-effects with hepatic steatosis and fibrosis in NAFLD"},{"key":"1990_CR23","doi-asserted-by":"publisher","unstructured":"Li J, Zhao F, Wang Y, Chen J, Tao J, Tian G, et al. Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome. 2017;5:1\u201319. Available from: https:\/\/doi.org\/10.1186\/s40168-016-0222-x.","DOI":"10.1186\/s40168-016-0222-x"},{"issue":"16","key":"1990_CR24","doi-asserted-by":"crossref","first-page":"e2100536","DOI":"10.1002\/advs.202100536","volume":"8","author":"J Zhang","year":"2021","unstructured":"Zhang J, Ni Y, Qian L, Fang Q, Zheng T, Zhang M, et al. Decreased Abundance of Akkermansia muciniphila Leads to the Impairment of Insulin Secretion and Glucose Homeostasis in Lean Type 2 Diabetes. Adv Sci. 2021;8(16):e2100536.","journal-title":"Adv Sci."},{"key":"1990_CR25","doi-asserted-by":"publisher","unstructured":"Liu Y, Wang Y, Ni Y, Cheung CKY, Lam KSL, Wang Y, et al. Gut Microbiome Fermentation Determines the Efficacy of Exercise for Diabetes Prevention. Cell Metab. 2020;31:77\u201391.e5. Available from: https:\/\/doi.org\/10.1016\/j.cmet.2019.11.001.","DOI":"10.1016\/j.cmet.2019.11.001"},{"key":"1990_CR26","doi-asserted-by":"publisher","unstructured":"Jie Z, Xia H, Zhong SL, Feng Q, Li S, Liang S, et al. The gut microbiome in atherosclerotic cardiovascular disease. Nat Commun. 2017;8:1\u201311. Available from: https:\/\/doi.org\/10.1038\/s41467-017-00900-1.","DOI":"10.1038\/s41467-017-00900-1"},{"key":"1990_CR27","first-page":"347","volume":"3","author":"RS Mehta","year":"2018","unstructured":"Mehta RS, Abu-ali GS, Drew DA, Lloyd-price J, Lochhead P, Joshi AD, et al. Stability of the human faecal microbiome in a cohort of adult men. 2018;3:347\u201355.","journal-title":"Stability of the human faecal microbiome in a cohort of adult men"},{"key":"1990_CR28","doi-asserted-by":"publisher","unstructured":"Pasolli E, Schiffer L, Manghi P, Renson A, Obenchain V, Truong DT, et al. Accessible, curated metagenomic data through ExperimentHub. Nat Methods. 2017;14:1023\u20134. Available from: https:\/\/doi.org\/10.1038\/nmeth.4468.","DOI":"10.1038\/nmeth.4468"},{"issue":"1","key":"1990_CR29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/HJH.0000000000000065","volume":"32","author":"MA Weber","year":"2014","unstructured":"Weber MA, Schiffrin EL, White WB, Mann S, Lindholm LH, Kenerson JG, et al. Clinical practice guidelines for the management of hypertension inthe community a statement by the American society of hypertension and the International Society of Hypertension. J Hypertens. 2014;32(1):3\u201315.","journal-title":"J Hypertens."},{"key":"1990_CR30","doi-asserted-by":"crossref","unstructured":"WHO. Use of Glycated Haemoglobin (HbA1c) in the diagnosis of diabetes mellitus: abbreviated report of a WHO consultation. approved by the guidelines review committee. World Heal Organ. 2011;299\u2013309.","DOI":"10.1016\/j.diabres.2011.03.012"},{"issue":"1","key":"1990_CR31","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s40168-019-0658-x","volume":"7","author":"EL Clarke","year":"2019","unstructured":"Clarke EL, Taylor LJ, Zhao C, Connell A, Lee J, Fett B, et al. Sunbeam\u202f: an extensible pipeline for analyzing metagenomic sequencing experiments. Microbiome. 2019;7(1):46.","journal-title":"Microbiome."},{"issue":"14","key":"1990_CR32","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Durbin R. Fast and accurate short read alignment with Burrows \u2013 Wheeler transform. Bioinformatics. 2009;25(14):1754\u201360.","journal-title":"Bioinformatics"},{"key":"1990_CR33","first-page":"2114","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger AM, Lohse M, Usadel B. Genome analysis Trimmomatic\u202f: a flexible trimmer for Illumina sequence data. 2014;30:2114\u201320.","journal-title":"Genome analysis Trimmomatic : a flexible trimmer for Illumina sequence data"},{"key":"1990_CR34","doi-asserted-by":"crossref","unstructured":"Beghini F, McIver LJ, Blanco-M\u00edguez A, Dubois L, Asnicar F, Maharjan S, et al. Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3. Elife. 2021;10. Available from: PMC8096432. Cited 2022 Jan 28.","DOI":"10.7554\/eLife.65088"},{"key":"1990_CR35","doi-asserted-by":"crossref","first-page":"D455","DOI":"10.1093\/nar\/gkz862","volume":"48","author":"R Caspi","year":"2020","unstructured":"Caspi R, Billington R, Keseler IM, Kothari A, Krummenacker M, Midford PE, et al. The MetaCyc database of metabolic pathways and enzymes-a 2019 update. Nucleic Acids Res. 2020;48:D455\u2013D453.","journal-title":"Nucleic Acids Res"},{"key":"1990_CR36","doi-asserted-by":"crossref","unstructured":"Kanehisa M, Goto S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 2000;28:27. Available from: PMC102409. Cited 2021 Nov 2.","DOI":"10.1093\/nar\/28.1.27"},{"key":"1990_CR37","doi-asserted-by":"crossref","unstructured":"Dixon P. VEGAN, a package of R functions for community ecology. J Veg Sci. 2003;14:927\u201330. Available from:\u00a0http:\/\/doi.wiley.com\/10.1111\/j.1654-1103.2002.tb02049.x.","DOI":"10.1111\/j.1654-1103.2003.tb02228.x"},{"key":"1990_CR38","doi-asserted-by":"crossref","unstructured":"Benjamini Y, Hochberg Y, Benjamini, Yoav HY. Controlling The False Discovery Rate - A Practical And Powerful Approach To Multiple Testing. J. R. Stat. Soc. Ser. B. 1995. p. 289\u2013300. Available from: http:\/\/www.stat.purdue.edu\/~doerge\/BIOINFORM.D\/FALL06\/Benjamini and Y FDR.pdf%5Cn\u00a0http:\/\/engr.case.edu\/ray_soumya\/mlrg\/controlling_fdr_benjamini95.pdf.","DOI":"10.1111\/j.2517-6161.1995.tb02031.x"},{"key":"1990_CR39","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nbt.3703","volume":"35","author":"S Magn\u00fasd\u00f3ttir","year":"2017","unstructured":"Magn\u00fasd\u00f3ttir S, Heinken A, Kutt L, Ravcheev DA, Bauer E, Noronha A, et al. Generation of genome-scale metabolic reconstructions for 773 members of the human gut microbiota. Nat Biotechnol. 2017;35:81\u20139.","journal-title":"Nat Biotechnol"},{"key":"1990_CR40","doi-asserted-by":"crossref","first-page":"7542","DOI":"10.1093\/nar\/gky537","volume":"46","author":"D Machado","year":"2018","unstructured":"Machado D, Andrejev S, Tramontano M, Patil KR. Fast automated reconstruction of genome-scale metabolic models for microbial species and communities. Nucleic Acids Res. 2018;46:7542\u201353.","journal-title":"Nucleic Acids Res"},{"key":"1990_CR41","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/bioinformatics\/btr597","volume":"28","author":"DJ Stekhoven","year":"2012","unstructured":"Stekhoven DJ, B\u00fchlmann P. Missforest-Non-parametric missing value imputation for mixed-type data. Bioinformatics. 2012;28:112\u20138.","journal-title":"Bioinformatics"},{"issue":"1","key":"1990_CR42","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1038\/s41467-017-01973-8","volume":"8","author":"C Duvallet","year":"2017","unstructured":"Duvallet C, Gibbons SM, Gurry T, Irizarry RA, Alm EJ. Meta-analysis of gut microbiome studies identifies disease-specific and shared responses. Nat Commun. 2017;8(1):1784.","journal-title":"Nat Commun."},{"key":"1990_CR43","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/s41564-022-01121-z","volume":"7","author":"S Priya","year":"2022","unstructured":"Priya S, Burns MB, Ward T, Mars RAT, Adamowicz B, Lock EF, et al. Identification of shared and disease-specific host gene\u2013microbiome associations across human diseases using multi-omic integration. Nat Microbiol. 2022;7:780\u201395.","journal-title":"Nat Microbiol"},{"issue":"7","key":"1990_CR44","first-page":"48","volume":"223","author":"A Max","year":"2022","unstructured":"Max A, Wing J, Weston S, Williams A, Keefer C, Engelhardt A, et al. Package \u2018 caret \u2019 R topics documented. R Journal. 2022;223(7):48.","journal-title":"R Journal."},{"key":"1990_CR45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i11","volume":"36","author":"MB Kursa","year":"2010","unstructured":"Kursa MB, Rudnicki WR. Feature selection with the boruta package. J Stat Softw. 2010;36:1\u201313.","journal-title":"J Stat Softw"},{"key":"1990_CR46","unstructured":"Greenwell B. fastshap: Fast Approximate Shapley Values. R package. 2024. https:\/\/CRAN.R-project.org\/package=fastshap."},{"key":"1990_CR47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13059-021-02306-1","volume":"22","author":"J Wirbel","year":"2021","unstructured":"Wirbel J, Zych K, Essex M, Karcher N, Kartal E, Salazar G, et al. Microbiome meta-analysis and cross-disease comparison enabled by the SIAMCAT machine learning toolbox. Genome Biol. 2021;22:1\u201327.","journal-title":"Genome Biol"},{"key":"1990_CR48","doi-asserted-by":"crossref","unstructured":"Song W-M, Zhang B. Multiscale Embedded Gene Co-expression Network Analysis. PLOS Comput Biol. 2015;11:e1004574. Available from:\u00a0https:\/\/journals.plos.org\/ploscompbiol\/article?id=10.1371\/journal.pcbi.1004574. Cited 2021 Nov 3.\u00a0","DOI":"10.1371\/journal.pcbi.1004574"},{"key":"1990_CR49","doi-asserted-by":"crossref","unstructured":"McKenzie AT, Katsyv I, Song W-M, Wang M, Zhang B. DGCA: A comprehensive R package for Differential Gene Correlation Analysis. BMC Syst Biol 2016 101. 2016 ;10:1\u201325. Available from: https:\/\/bmcsystbiol.biomedcentral.com\/articles\/10.1186\/s12918-016-0349-1. Cited 2021 Nov 3.","DOI":"10.1186\/s12918-016-0349-1"},{"key":"1990_CR50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-230X-6-33","volume":"6","author":"G Bedogni","year":"2006","unstructured":"Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, et al. The fatty liver index: A simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:1\u20137.","journal-title":"BMC Gastroenterol"},{"key":"1990_CR51","doi-asserted-by":"publisher","unstructured":"Kotronen A, Peltonen M, Hakkarainen A, Sevastianova K, Bergholm R, Johansson LM, et al. Prediction of Non-Alcoholic Fatty Liver Disease and Liver Fat Using Metabolic and Genetic Factors. Gastroenterology. 2009;137:865\u201372. Available from: https:\/\/doi.org\/10.1053\/j.gastro.2009.06.005.","DOI":"10.1053\/j.gastro.2009.06.005"},{"key":"1990_CR52","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/biostatistics\/kxp008","volume":"10","author":"DM Witten","year":"2009","unstructured":"Witten DM, Tibshirani R, Hastie T. A penalized matrix decomposition, with applications to sparse principal components and canonical correlation analysis. Biostatistics. 2009;10:515\u201334.","journal-title":"Biostatistics"},{"issue":"7","key":"1990_CR53","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3390\/genes10070524","volume":"10","author":"B Hamidi","year":"2019","unstructured":"Hamidi B, Wallace K, Alekseyenko AV. MODIMA, a method for multivariate omnibus distance mediation analysis, allows for integration of multivariate exposure\u2013mediator\u2013response relationships. Genes (Basel). 2019;10(7):524.","journal-title":"Genes (Basel)."},{"key":"1990_CR54","unstructured":"Yi Z. mediation: R Package for Causal Mediation Analysis. J Stat Softw. 2008;59:23\u201338. Available from: http:\/\/www.jstatsoft.org\/."},{"key":"1990_CR55","doi-asserted-by":"crossref","first-page":"6449","DOI":"10.1073\/pnas.1421834112","volume":"112","author":"A Zelezniak","year":"2015","unstructured":"Zelezniak A, Andrejev S, Ponomarova O, Mende DR, Bork P, Patil KR. Metabolic dependencies drive species co-occurrence in diverse microbial communities. Proc Natl Acad Sci U S A. 2015;112:6449\u201354.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1990_CR56","doi-asserted-by":"publisher","unstructured":"Friedman J, Tibshirani R, Hastie T. Regularization paths for generalized linear models via coordinate descent. J Stat Soft. 2010;33(1):1\u201322. https:\/\/doi.org\/10.18637\/jss.v033.i01.","DOI":"10.18637\/jss.v033.i01"},{"key":"1990_CR57","first-page":"35","volume":"26","author":"S Reid","year":"2016","unstructured":"Reid S, Tibshirani R, Friedman J. A study of error variance estimation in lasso regression. Stat Sin. 2016;26:35\u201367.","journal-title":"Stat Sin"},{"issue":"6","key":"1990_CR58","first-page":"665","volume":"22","author":"S Kim","year":"2015","unstructured":"Kim S. ppcor: An R package for a fast calculation to semi-partial correlation coefficients. Commun Stat Appl Methods. 2015;22(6):665\u201374.","journal-title":"Commun Stat Appl Methods."},{"key":"1990_CR59","doi-asserted-by":"crossref","unstructured":"Wickham H. ggplot2: Elegant graphics for data analysis. Springer-Verlag New York; 2016. Available from: https:\/\/ggplot2.tidyverse.org.","DOI":"10.1007\/978-3-319-24277-4_9"},{"key":"1990_CR60","doi-asserted-by":"crossref","unstructured":"Gu Z, Eils R, Schlesner M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics. 2016;32:2847\u20139. Available from: https:\/\/academic.oup.com\/bioinformatics\/article\/32\/18\/2847\/1743594. Cited 2021 Nov 2.","DOI":"10.1093\/bioinformatics\/btw313"},{"key":"1990_CR61","doi-asserted-by":"crossref","unstructured":"Otasek D, Morris JH, Bou\u00e7as J, Pico AR, Demchak B. Cytoscape Automation: empowering workflow-based network analysis. Genome Biol. 2019;20. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31477170\/. Cited 2021 Nov 2.","DOI":"10.1186\/s13059-019-1758-4"},{"key":"1990_CR62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/gigascience\/gix047","volume":"6","author":"P ten Hoopen","year":"2017","unstructured":"ten Hoopen P, Finn RD, Bongo LA, Corre E, Fosso B, Meyer F, et al. The metagenomic data life-cycle: Standards and best practices. Gigascience. 2017;6:1\u201311.","journal-title":"Gigascience"},{"key":"1990_CR63","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.2217\/fmb.15.87","volume":"10","author":"V Thomas","year":"2015","unstructured":"Thomas V, Clark J, Dor\u00e9 J. Fecal microbiota analysis: An overview of sample collection methods and sequencing strategies. Future Microbiol. 2015;10:1485\u2013504.","journal-title":"Future Microbiol"},{"key":"1990_CR64","doi-asserted-by":"publisher","unstructured":"Garza DR, Van Verk MC, Huynen MA, Dutilh BE. Towards predicting the environmental metabolome from metagenomics with a mechanistic model. Nat Microbiol. 2018;3:456\u201360. Available from: https:\/\/doi.org\/10.1038\/s41564-018-0124-8.","DOI":"10.1038\/s41564-018-0124-8"},{"key":"1990_CR65","doi-asserted-by":"publisher","unstructured":"Lee JWJ, Plichta DR, Asher S, Delsignore M, Jeong T, McGoldrick J, et al. Association of distinct microbial signatures with premalignant colorectal adenomas. Cell Host Microbe. 2023;31:827\u2013838.e3. Available from: https:\/\/doi.org\/10.1016\/j.chom.2023.04.007.","DOI":"10.1016\/j.chom.2023.04.007"},{"key":"1990_CR66","unstructured":"Ho TK. Random Decision Forests. Proc 3rd Int Conf Doc Anal Recognit. 1995;"},{"key":"1990_CR67","doi-asserted-by":"publisher","unstructured":"Udayappan S, Manneras-Holm L, Chaplin-Scott A, Belzer C, Herrema H, Dallinga-Thie GM, et al. Oral treatment with Eubacterium hallii improves insulin sensitivity in db\/db mice. npj Biofilms Microbiomes. 2016;2. Available from: https:\/\/doi.org\/10.1038\/npjbiofilms.2016.9.","DOI":"10.1038\/npjbiofilms.2016.9"},{"key":"1990_CR68","doi-asserted-by":"publisher","unstructured":"Almeida D, Machado D, Andrade JC, Mendo S, Gomes AM, Freitas AC. Evolving trends in next-generation probiotics: a 5W1H perspective. Crit Rev Food Sci Nutr. 2020;60:1783\u201396. Available from: https:\/\/doi.org\/10.1080\/10408398.2019.1599812.","DOI":"10.1080\/10408398.2019.1599812"},{"key":"1990_CR69","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/liv.14743","volume":"41","author":"VD de Mello","year":"2021","unstructured":"de Mello VD, Sehgal R, M\u00e4nnist\u00f6 V, Kl\u00e5vus A, Nilsson E, Perfilyev A, et al. Serum aromatic and branched-chain amino acids associated with NASH demonstrate divergent associations with serum lipids. Liver Int. 2021;41:754\u201363.","journal-title":"Liver Int"},{"key":"1990_CR70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nu9070642","volume":"9","author":"M Goffredo","year":"2017","unstructured":"Goffredo M, Santoro N, Tric\u00f2 D, Giannini C, D\u2019Adamo E, Zhao H, et al. A branched-chain amino acid-related metabolic signature characterizes obese adolescents with non-alcoholic fatty liver disease. Nutrients. 2017;9:1\u201312.","journal-title":"Nutrients"},{"key":"1990_CR71","doi-asserted-by":"crossref","first-page":"6404","DOI":"10.3748\/wjg.v25.i43.6404","volume":"25","author":"XX Yang","year":"2019","unstructured":"Yang XX, Di WJ, Mu JK, Liu X, Li FJ, Li YQ, et al. Mitochondrial metabolomic profiling for elucidating the alleviating potential of Polygonatum kingianum against high-fat diet-induced nonalcoholic fatty liver disease. World J Gastroenterol. 2019;25:6404\u201315.","journal-title":"World J Gastroenterol"},{"key":"1990_CR72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40168-021-01052-7","volume":"9","author":"J Mayneris-Perxachs","year":"2021","unstructured":"Mayneris-Perxachs J, Cardellini M, Hoyles L, Latorre J, Davato F, Moreno-Navarrete JM, et al. Iron status influences non-alcoholic fatty liver disease in obesity through the gut microbiome. Microbiome. 2021;9:1\u201318.","journal-title":"Microbiome"},{"key":"1990_CR73","doi-asserted-by":"publisher","unstructured":"Tang Y, Chen X, Chen Q, Xiao J, Mi J, Liu Q, et al. Association of serum methionine metabolites with non-alcoholic fatty liver disease: a cross-sectional study. Nutr Metab. 2022;19:1\u201312. Available from: https:\/\/doi.org\/10.1186\/s12986-022-00647-7.","DOI":"10.1186\/s12986-022-00647-7"},{"key":"1990_CR74","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.bbrc.2020.04.001","volume":"526","author":"P Ma","year":"2020","unstructured":"Ma P, Huang R, Jiang J, Ding Y, Li T, Ou Y. Potential use of C-phycocyanin in non-alcoholic fatty liver disease. Biochem Biophys Res Commun. 2020;526:906\u201312.","journal-title":"Biochem Biophys Res Commun"},{"key":"1990_CR75","doi-asserted-by":"crossref","unstructured":"Ferrannini E, Iervasi G, Cobb J, Ndreu R, Nannipieri M. Insulin resistance and normal thyroid hormone levels: prospective study and metabolomic analysis. Am J Physiol Endocrinol Metab. 2017;312:429\u201336. Available from: http:\/\/www.ajpendo.org.","DOI":"10.1152\/ajpendo.00464.2016"},{"key":"1990_CR76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/659029","volume":"2014","author":"SY Tang","year":"2014","unstructured":"Tang SY, Cheah IKM, Ng PE, Hoi A, Jenner AM. Heme Consumption Reduces Hepatic Triglyceride and Fatty Acid Accumulation in a Rat Model of NAFLD Fed Westernized Diet. ISRN Oxidative Med. 2014;2014:1\u20137.","journal-title":"ISRN Oxidative Med"},{"issue":"5","key":"1990_CR77","doi-asserted-by":"crossref","first-page":"dmm039206","DOI":"10.1242\/dmm.039206","volume":"12","author":"S Carbajo-Pescador","year":"2019","unstructured":"Carbajo-Pescador S, Porras D, Garcia-Mediavilla MV, Martinez-Florez S, Juarez-Fernandez M, Cuevas MJ, et al. Beneficial effects of exercise on gut microbiota functionality and barrier integrity, and gut-liver crosstalk in an in vivo model of early obesity and non-alcoholic fatty liver disease. DMM Dis Model Mech. 2019;12(5):dmm039206.","journal-title":"DMM Dis Model Mech."},{"issue":"3","key":"1990_CR78","doi-asserted-by":"crossref","first-page":"dmm048355","DOI":"10.1242\/dmm.048355","volume":"14","author":"M Kalyesubula","year":"2021","unstructured":"Kalyesubula M, Mopuri R, Asiku J, Rosov A, Yosefi S, Edery N, et al. High-dose vitamin B1 therapy prevents the development of experimental fatty liver driven by overnutrition. DMM Dis Model Mech. 2021;14(3):dmm048355.","journal-title":"DMM Dis Model Mech."},{"key":"1990_CR79","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s11011-016-9941-8","volume":"32","author":"T Xu","year":"2017","unstructured":"Xu T, Zhou J, Zhu J, Zhang S, Zhang N, Zhao Y, et al. Carnosic acid protects non-alcoholic fatty liver-induced dopaminergic neuron injury in rats. Metab Brain Dis. 2017;32:483\u201391.","journal-title":"Metab Brain Dis"},{"key":"1990_CR80","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/jgh.12832","volume":"30","author":"JY Shin","year":"2015","unstructured":"Shin JY, Kim MJ, Kim ES, Mo EY, Moon SD, Han JH, et al. Association between serum calcium and phosphorus concentrations with non-alcoholic fatty liver disease in Korean population. J Gastroenterol Hepatol. 2015;30:733\u201341.","journal-title":"J Gastroenterol Hepatol"},{"key":"1990_CR81","doi-asserted-by":"crossref","first-page":"109511","DOI":"10.1016\/j.foodres.2020.109511","volume":"136","author":"ZR Huang","year":"2020","unstructured":"Huang ZR, Chen M, Guo WL, Li TT, Liu B, Bai WD, et al. Monascus purpureus-fermented common buckwheat protects against dyslipidemia and non-alcoholic fatty liver disease through the regulation of liver metabolome and intestinal microbiome. Food Res Int. 2020;136:109511.","journal-title":"Food Res Int."},{"key":"1990_CR82","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1002\/hep4.1601","volume":"4","author":"JJ Witjes","year":"2020","unstructured":"Witjes JJ, Smits LP, Pekmez CT, Prodan A, Meijnikman AS, Troelstra MA, et al. Donor Fecal Microbiota Transplantation Alters Gut Microbiota and Metabolites in Obese Individuals With Steatohepatitis. Hepatol Commun. 2020;4:1578\u201390.","journal-title":"Hepatol Commun"},{"key":"1990_CR83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2019.00611","volume":"10","author":"F Grabherr","year":"2019","unstructured":"Grabherr F, Grander C, Effenberger M, Adolph TE, Tilg H. Gut Dysfunction and Non-alcoholic Fatty Liver Disease. Front Endocrinol (Lausanne). 2019;10:1\u20139.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1990_CR84","doi-asserted-by":"publisher","unstructured":"Brahe LK, Le Chatelier E, Prifti E, Pons N, Kennedy S, Hansen T, et al. Specific gut microbiota features and metabolic markers in postmenopausal women with obesity. Nutr Diabetes. 2015;5:e159\u20137. Available from: https:\/\/doi.org\/10.1038\/nutd.2015.9.","DOI":"10.1038\/nutd.2015.9"},{"key":"1990_CR85","first-page":"1","volume":"11","author":"K Nie","year":"2021","unstructured":"Nie K, Ma K, Luo W, Shen Z, Yang Z, Xiao M, et al. Roseburia intestinalis: A Beneficial Gut Organism From the Discoveries in Genus and Species. Front Cell Infect Microbiol. 2021;11:1\u201315.","journal-title":"Front Cell Infect Microbiol"},{"key":"1990_CR86","doi-asserted-by":"crossref","first-page":"178.e1","DOI":"10.1016\/j.cmi.2015.10.003","volume":"22","author":"MAM Rogers","year":"2016","unstructured":"Rogers MAM, Aronoff DM. The influence of non-steroidal anti-inflammatory drugs on the gut microbiome. Clin Microbiol Infect. 2016;22:178.e1-178.e9.","journal-title":"Clin Microbiol Infect"},{"key":"1990_CR87","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/apt.14451","volume":"47","author":"Q Le Bastard","year":"2018","unstructured":"Le Bastard Q, Al-Ghalith GA, Gr\u00e9goire M, Chapelet G, Javaudin F, Dailly E, et al. Systematic review: human gut dysbiosis induced by non-antibiotic prescription medications. Aliment Pharmacol Ther. 2018;47:332\u201345.","journal-title":"Aliment Pharmacol Ther"},{"key":"1990_CR88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40246-020-00260-w","volume":"14","author":"CN Brocker","year":"2020","unstructured":"Brocker CN, Velenosi T, Flaten HK, McWilliams G, McDaniel K, Shelton SK, et al. Metabolomic profiling of metoprolol hypertension treatment reveals altered gut microbiota-derived urinary metabolites. Hum Genomics. 2020;14:1\u20139.","journal-title":"Hum Genomics"},{"key":"1990_CR89","first-page":"1","volume":"13","author":"X Yuan","year":"2022","unstructured":"Yuan X, Wang R, Han B, Sun CJ, Chen R, Wei H, et al. Functional and metabolic alterations of gut microbiota in children with new-onset type 1 diabetes. Nat Commun. 2022;13:1\u201316.","journal-title":"Nat Commun"},{"issue":"10","key":"1990_CR90","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1136\/gutjnl-2022-328256","volume":"72","author":"Z Shi","year":"2022","unstructured":"Shi Z, Hu G, Li MW, Zhang L, Li X, Li L, et al. Gut microbiota as non-invasive diagnostic and prognostic biomarkers for natural killer\/T-cell lymphoma. Gut. 2022;72(10):1999\u20132002.","journal-title":"Gut."},{"key":"1990_CR91","first-page":"1","volume":"13","author":"Q Su","year":"2022","unstructured":"Su Q, Liu Q, Lau RI, Zhang J, Xu Z, Yeoh YK, et al. Faecal microbiome-based machine learning for multi-class disease diagnosis. Nat Commun. 2022;13:1\u20138.","journal-title":"Nat Commun"},{"key":"1990_CR92","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1136\/gutjnl-2021-324755","volume":"71","author":"E Kartal","year":"2022","unstructured":"Kartal E, Schmidt TSB, Molina-Montes E, Rodr\u00edguez-Perales S, Wirbel J, Maistrenko OM, et al. A faecal microbiota signature with high specificity for pancreatic cancer. Gut. 2022;71:1359\u201372.","journal-title":"Gut"},{"key":"1990_CR93","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1111\/jgh.15487","volume":"36","author":"M Iwaki","year":"2021","unstructured":"Iwaki M, Kessoku T, Ozaki A, Kasai Y, Kobayashi T, Nogami A, et al. Gut microbiota composition associated with hepatic fibrosis in non-obese patients with non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2021;36:2275\u201384.","journal-title":"J Gastroenterol Hepatol"},{"key":"1990_CR94","doi-asserted-by":"publisher","unstructured":"Duarte SMB, Stefano JT, Miele L, Ponziani FR, Souza-Basqueira M, Okada LSRR, et al. Gut microbiome composition in lean patients with NASH is associated with liver damage independent of caloric intake: A prospective pilot study. Nutr Metab Cardiovasc Dis. 2018;28:369\u201384. Available from: https:\/\/doi.org\/10.1016\/j.numecd.2017.10.014.","DOI":"10.1016\/j.numecd.2017.10.014"},{"key":"1990_CR95","doi-asserted-by":"publisher","unstructured":"Banerjee S, Walder F, B\u00fcchi L, Meyer M, Held AY, Gattinger A, et al. Agricultural intensification reduces microbial network complexity and the abundance of keystone taxa in roots. ISME J. 2019;13:1722\u201336. Available from: https:\/\/doi.org\/10.1038\/s41396-019-0383-2.","DOI":"10.1038\/s41396-019-0383-2"},{"key":"1990_CR96","doi-asserted-by":"publisher","unstructured":"Rao C, Coyte KZ, Bainter W, Geha RS, Martin CR, Rakoff-Nahoum S. Multi-kingdom ecological drivers of microbiota assembly in preterm infants. Nature. 2021;591:633\u20138. Available from: https:\/\/doi.org\/10.1038\/s41586-021-03241-8.\u00a0","DOI":"10.1038\/s41586-021-03241-8"},{"key":"1990_CR97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13059-020-02207-9","volume":"22","author":"L Xiao","year":"2021","unstructured":"Xiao L, Wang J, Zheng J, Li X, Zhao F. Deterministic transition of enterotypes shapes the infant gut microbiome at an early age. Genome Biol. 2021;22:1\u201321.","journal-title":"Genome Biol"},{"issue":"1","key":"1990_CR98","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1038\/s41467-022-29968-0","volume":"13","author":"R Cheng","year":"2022","unstructured":"Cheng R, Wang L, Le S, Yang Y, Zhao C, Zhang X, et al. A randomized controlled trial for response of microbiome network to exercise and diet intervention in patients with nonalcoholic fatty liver disease. Nat Commun. 2022;13(1):2555.","journal-title":"Nat Commun."},{"key":"1990_CR99","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.chom.2022.04.005","volume":"30","author":"J Samara","year":"2022","unstructured":"Samara J, Moossavi S, Alshaikh B, Ortega VA, Pettersen VK, Ferdous T, et al. Supplementation with a probiotic mixture accelerates gut microbiome maturation and reduces intestinal inflammation in extremely preterm infants. Cell Host Microbe. 2022;30:696-711.e5.","journal-title":"Cell Host Microbe"},{"issue":"8","key":"1990_CR100","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1038\/s41396-022-01253-4","volume":"16","author":"H Liu","year":"2022","unstructured":"Liu H, Liao C, Wu L, Tang J, Chen J, Lei C, et al. Ecological dynamics of the gut microbiome in response to dietary fiber. ISME J. 2022;16(8):2040\u201355.","journal-title":"ISME J."},{"key":"1990_CR101","doi-asserted-by":"publisher","unstructured":"Iacono A, Raso GM, Canani RB, Calignano A, Meli R. Probiotics as an emerging therapeutic strategy to treat NAFLD: Focus on molecular and biochemical mechanisms. J Nutr Biochem. 2011;22:699\u2013711. Available from: https:\/\/doi.org\/10.1016\/j.jnutbio.2010.10.002.","DOI":"10.1016\/j.jnutbio.2010.10.002"}],"container-title":["Microbiome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40168-024-01990-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40168-024-01990-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40168-024-01990-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T19:10:37Z","timestamp":1739387437000},"score":1,"resource":{"primary":{"URL":"https:\/\/microbiomejournal.biomedcentral.com\/articles\/10.1186\/s40168-024-01990-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,14]]},"references-count":101,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1990"],"URL":"https:\/\/doi.org\/10.1186\/s40168-024-01990-y","relation":{},"ISSN":["2049-2618"],"issn-type":[{"value":"2049-2618","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,14]]},"assertion":[{"value":"3 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"For the cohorts that are not associated with a published study, ethics approvals were obtained by the Shanghai Jiao Tong University Affiliated Sixth People\u2019s Hospital (approval no: 2015-65-(1)) and the University of Hong Kong \/ Hospital Authority Hong Kong West Cluster (approval no: UW 20-700) following the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from all participants from all the cohorts that are not associated with a published study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"M.N. is founder and scientific advisor of Caelus Health that is commercializing A. soehngenii for metabolic disease treatment. R.L. serves as a consultant to Aardvark Therapeutics, Altimmune, Arrowhead Pharmaceuticals, AstraZeneca, Cascade Pharmaceuticals, Eli Lilly, Gilead, Glympse bio, Inipharma, Intercept, Inventiva, Ionis, Janssen Inc., Lipidio, Madrigal, Neurobo, Novo Nordisk, Merck, Pfizer, Sagimet, 89 bio, Takeda, Terns Pharmaceuticals and Viking Therapeutics. In addition, his institution received research grants from Arrowhead Pharmaceuticals, Astrazeneca, Boehringer-Ingelheim, Bristol-Myers Squibb, Eli Lilly, Galectin Therapeutics, Gilead, Intercept, Hanmi, Intercept, Inventiva, Ionis, Janssen, Madrigal Pharmaceuticals, Merck, Novo Nordisk, Pfizer, Sonic Incytes and Terns Pharmaceuticals. Co-founder of LipoNexus Inc. All other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}